62
Growth Score
pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
516747
Annogen focuses on controlled gene expression for cell and gene therapy, protein and virus production.
- Joris van Arensbergen: Founder and CEO
About the Company
Annogen specializes in biotechnology, focusing on controlled gene expression for cell and gene therapy, as well as protein and virus production. The company offers promoter screens, including inducible promoters, and functional annotation of non-coding sequence variants. Annogen's expertise extends to synthetic biology and the functional
annotation of the non-coding genome. The company has completed numerous programs for biopharma clients such as Orchard Therapeutics, uniQure, Meira GTx, and VectorY.
